signature=6969ead648b6b29237d72f5c6eb9ceaa,Receptor Binding Targets for Antipsychotic Efficacy

Acknowledgements

Supported by the Department of Veterans Affairs Medical Research Service, and National Institute of Mental Health (R21MH083192-01).

Conflict of InterestThe authors disclose the following relationships which might potentially bias this work:

Neil M. Richtand: Consultant: Bristol-Meyers Squibb, Gerson Lehrman Group, Sunovion Pharmaceuticals Inc./Sepracor. Speaker’s Bureau: Bristol-Meyers Squibb, Otsuka America Pharmaceutical, Schering - Plough Corporation/Merck, Novartis Pharmaceuticals, Sunovion Pharmaceuticals Inc./Sepracor. Grant/Research Support: Ortho-McNeil Janssen Scientific Affairs, LLC; AstraZeneca Pharmaceuticals